Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T21307 | Target Info | |||
Target Name | MAPK-activated protein kinase 2 (MAPKAPK2) | ||||
Synonyms | MK2; MK-2; MAPKactivated protein kinase 2; MAPKAPK-2; MAPKAP-K2; MAPKAP kinase 2; MAP kinaseactivated protein kinase 2; MAP kinase-activated protein kinase 2 | ||||
Target Type | Clinical trial Target | ||||
Gene Name | MAPKAPK2 | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Heat shock proteins | [+] 1 Heat shock proteins | + | |||
Interacting Protein Name | Heat shock protein beta-1 (HSPB1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Stress-responsive protein 27; SRP27; HspB1; HSP28; HSP 27; Heat shock protein beta-1; Heat shock 27 kDa protein; Estrogen-regulated 24 kDa protein; 28 kDa heat shock protein | ||||
Evidence Score (E-score) | 17 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Biochemical Activity | [2] | |||
3 | Biochemical Activity | [3] | |||
4 | Biochemical Activity | [4] | |||
5 | Biochemical Activity | [5] | |||
6 | Biochemical Activity | [6] | |||
7 | Biochemical Activity | [7] | |||
8 | Biochemical Activity | [8] | |||
9 | Biochemical Activity | [9] | |||
10 | Biochemical Activity | [10] | |||
11 | Biochemical Activity | [11] | |||
12 | Biochemical Activity | [12] | |||
13 | Biochemical Activity | [13] | |||
14 | Biochemical Activity | [14] | |||
15 | Biochemical Activity | [15] | |||
16 | Biochemical Activity | [16] | |||
17 | Reconstituted Complex | [1] | |||
Kinases | [+] 4 Kinases | + | |||
Interacting Target Name | Stress-activated protein kinase 2a (p38 alpha) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SAPK2A; P38 Mitogen-activatedprotein kinase alpha; P38 mitogen activatedprotein kinase; MXI2; Mitogen-activated protein kinase p38 alpha; Mitogen-activated protein kinase 14; MAX-interacting protein 2; MAPK 14; MAP kinase p38alpha; MAP kinase p38 alpha; MAP kinase MXI2; MAP kinase 14; Cytokine suppressive anti-inflammatory drug-binding protein; Cytokine suppressive anti-inflammatory drug binding protein; CSPB1; CSBP2; CSBP1; CSBP; CSAID-binding protein; CSAID binding protein; CRK1 | ||||
Evidence Score (E-score) | 7 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Affinity Capture-Western | [17] | |||
3 | Co-crystal Structure | [18] | |||
4 | Co-crystal Structure | [19] | |||
5 | Protein-Fragment Complementation Assay | [20] | |||
6 | Reconstituted Complex | [1] | |||
7 | Reconstituted Complex | [21] | |||
Interacting Target Name | RAC-alpha serine/threonine-protein kinase (AKT1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RAC-PK-alpha; RAC; Proto-oncogene c-Akt; Protein kinase B alpha; Protein kinase B; PKB alpha; PKB | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Co-localization | [22] | |||
3 | Reconstituted Complex | [1] | |||
Interacting Target Name | Extracellular signal-regulated kinase 2 (ERK2) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PRKM2; PRKM1; P42-MAPK; P42 Mitogen-activated protein kinase; Mitogen-activated protein kinase 2; Mitogen-activated protein kinase 1; MAPK 2; MAPK 1; MAP kinase isoform p42; MAP kinase 2; MAP kinase 1; ERT1; ERK-2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [10] | |||
2 | Protein-Fragment Complementation Assay | [20] | |||
Interacting Target Name | Stress-activated protein kinase 2b (p38 beta) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Stress-activated protein kinase-2; SAPK2b; SAPK2; PRKM11; P38b; P38-2; P38 Mitogen-activated protein kinase beta; Mitogen-activated protein kinase p38 beta; Mitogen-activated protein kinase 11; MAPK 11; MAP kinase p38 beta; MAP kinase 11 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [23] | |||
2 | Affinity Capture-Western | [24] | |||
Other proteins | [+] 1 Other proteins | + | |||
Interacting Protein Name | Polyhomeotic-like protein 2 (PHC2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | EDR2; HPH2; PH2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Protein-Fragment Complementation Assay | [20] | |||
2 | Yeast two hybrid | [25] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | p38 Kinase-dependent MAPKAPK-2 activation functions as 3-phosphoinositide-dependent kinase-2 for Akt in human neutrophils. J Biol Chem. 2001 Feb 2;276(5):3517-23. | ||||
REF 2 | Regulation of Hsp27 oligomerization, chaperone function, and protective activity against oxidative stress/tumor necrosis factor alpha by phosphorylation. J Biol Chem. 1999 Jul 2;274(27):18947-56. | ||||
REF 3 | Heat shock protein 27 controls apoptosis by regulating Akt activation. J Biol Chem. 2003 Jul 25;278(30):27828-35. | ||||
REF 4 | The p38 pathway provides negative feedback for Ras proliferative signaling. J Biol Chem. 2000 Dec 15;275(50):38973-80. | ||||
REF 5 | Protein kinase C-delta (PKC-delta ) is activated by type I interferons and mediates phosphorylation of Stat1 on serine 727. J Biol Chem. 2002 Apr 26;277(17):14408-16. | ||||
REF 6 | MAPK-activated protein kinase-2 participates in p38 MAPK-dependent and ERK-dependent functions in human neutrophils. Cell Signal. 2003 Nov;15(11):993-1001. | ||||
REF 7 | Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-alpha mRNA. J Biol Chem. 2007 Feb 9;282(6):3766-77. | ||||
REF 8 | Arachidonic acid promotes phosphorylation of 5-lipoxygenase at Ser-271 by MAPK-activated protein kinase 2 (MK2). J Biol Chem. 2002 Apr 26;277(17):14793-800. | ||||
REF 9 | A comparison of the substrate specificity of MAPKAP kinase-2 and MAPKAP kinase-3 and their activation by cytokines and cellular stress. FEBS Lett. 1996 Sep 2;392(3):209-14. | ||||
REF 10 | Chemotactic peptide N-formyl-met-leu-phe activation of p38 mitogen-activated protein kinase (MAPK) and MAPK-activated protein kinase-2 in human neutrophils. J Biol Chem. 1997 Jan 10;272(2):937-44. | ||||
REF 11 | MAPKAP kinase 2 phosphorylates tristetraprolin on in vivo sites including Ser178, a site required for 14-3-3 binding. J Biol Chem. 2004 Mar 12;279(11):10176-84. | ||||
REF 12 | MK2 SUMOylation regulates actin filament remodeling and subsequent migration in endothelial cells by inhibiting MK2 kinase and HSP27 phosphorylation. Blood. 2011 Feb 24;117(8):2527-37. | ||||
REF 13 | The AU-rich element mRNA decay-promoting activity of BRF1 is regulated by mitogen-activated protein kinase-activated protein kinase 2. RNA. 2008 May;14(5):950-9. | ||||
REF 14 | Identification of the p16-Arc subunit of the Arp 2/3 complex as a substrate of MAPK-activated protein kinase 2 by proteomic analysis. J Biol Chem. 2003 Sep 19;278(38):36410-7. | ||||
REF 15 | The phosphorylation of CapZ-interacting protein (CapZIP) by stress-activated protein kinases triggers its dissociation from CapZ. Biochem J. 2005 Jul 1;389(Pt 1):127-35. | ||||
REF 16 | p38- and MK2-dependent signalling promotes stress-induced centriolar satellite remodelling via 14-3-3-dependent sequestration of CEP131/AZI1. Nat Commun. 2015 Nov 30;6:10075. | ||||
REF 17 | Identification of two distinct regions of p38 MAPK required for substrate binding and phosphorylation. Biochem Biophys Res Commun. 1999 Dec 9;266(1):284-9. | ||||
REF 18 | Molecular basis of MAPK-activated protein kinase 2:p38 assembly. Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6353-8. | ||||
REF 19 | Crystal structure of the p38 alpha-MAPKAP kinase 2 heterodimer. J Biol Chem. 2007 Mar 30;282(13):9733-9. | ||||
REF 20 | Monitoring protein-protein interactions in mammalian cells by trans-SUMOylation. Biochem J. 2011 Sep 15;438(3):495-503. | ||||
REF 21 | Creation of a stress-activated p90 ribosomal S6 kinase. The carboxyl-terminal tail of the MAPK-activated protein kinases dictates the signal transduction pathway in which they function. J Biol Chem. 2000 Oct 13;275(41):31588-93. | ||||
REF 22 | Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network. J Proteome Res. 2014 Dec 5;13(12):5339-46. | ||||
REF 23 | The protein interaction landscape of the human CMGC kinase group. Cell Rep. 2013 Apr 25;3(4):1306-20. | ||||
REF 24 | Cell type-specific inhibition of the ETS transcription factor ER81 by mitogen-activated protein kinase-activated protein kinase 2. J Biol Chem. 2001 Nov 9;276(45):41856-61. | ||||
REF 25 | P66(ShcA) interacts with MAPKAP kinase 2 and regulates its activity. FEBS Lett. 2004 Apr 23;564(1-2):205-11. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.